189 related articles for article (PubMed ID: 36242848)
1. Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson's disease: A review.
Wang Q; Botchway BOA; Zhang Y; Liu X
Biomed Pharmacother; 2022 Dec; 156():113848. PubMed ID: 36242848
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.
Ding X; Jian T; Wu Y; Zuo Y; Li J; Lv H; Ma L; Ren B; Zhao L; Li W; Chen J
Biomed Pharmacother; 2019 Feb; 110():85-94. PubMed ID: 30466006
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid attenuates interleukin-1β-induced oxidative stress and exerts protective effects on chondrocytes through the Kelch-like ECH-associated protein 1 (Keap1)/ Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.
Zhu W; Tang H; Li J; Guedes RM; Cao L; Guo C
Bioengineered; 2022 Apr; 13(4):9233-9247. PubMed ID: 35378052
[TBL] [Abstract][Full Text] [Related]
4. Icariside II suppresses ferroptosis to protect against MPP
Fan W; Zhou J
Chin J Physiol; 2023; 66(6):437-445. PubMed ID: 38149556
[TBL] [Abstract][Full Text] [Related]
5. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
7. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
8. The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A; Yamamoto M
Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
[No Abstract] [Full Text] [Related]
9. Nrf2 as a potential target for Parkinson's disease therapy.
Niu Y; Zhang J; Dong M
J Mol Med (Berl); 2021 Jul; 99(7):917-931. PubMed ID: 33844027
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine as a Keap1-Nrf2 inhibitor: a new target for an old drug for Parkinson's disease therapy.
Unni S; Deshmukh P; Krishnappa G; Bharath MMS; Padmanabhan B
J Biomol Struct Dyn; 2023; 41(12):5367-5381. PubMed ID: 35713597
[TBL] [Abstract][Full Text] [Related]
11. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
12. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
13. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
14. Activation of KEAP1/NRF2 stress signaling involved in the molecular basis of hemin-induced cytotoxicity in human pro-erythroid K562 cells.
Georgiou-Siafis SK; Tsiftsoglou AS
Biochem Pharmacol; 2020 May; 175():113900. PubMed ID: 32156661
[TBL] [Abstract][Full Text] [Related]
15.
Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
[TBL] [Abstract][Full Text] [Related]
16. Keap1/Nrf2 signaling pathway participating in the progression of epilepsy via regulation of oxidative stress and ferroptosis in neurons.
Wang D; Cui Y; Gao F; Zheng W; Li J; Xian Z
Clinics (Sao Paulo); 2024; 79():100372. PubMed ID: 38733688
[TBL] [Abstract][Full Text] [Related]
17. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
18. Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats.
Zhang T; Wu P; Budbazar E; Zhu Q; Sun C; Mo J; Peng J; Gospodarev V; Tang J; Shi H; Zhang JH
Stroke; 2019 Apr; 50(4):978-988. PubMed ID: 30890112
[TBL] [Abstract][Full Text] [Related]
19. Keap1 as Target of Genistein on Nrf2 Signaling Pathway Antagonizing Aβ induced Oxidative Damage of Cerebrovascular Endothelial Cells.
Xi YD; Li XY; Chi YF; Han J; Li HR; Wang XY; Wang X; Li TT; Yu HY; Xiao R
Curr Neurovasc Res; 2022; 19(1):73-82. PubMed ID: 35388754
[TBL] [Abstract][Full Text] [Related]
20. Effects of zearalenone-induced oxidative stress and Keap1-Nrf2 signaling pathway-related gene expression in the ileum and mesenteric lymph nodes of post-weaning gilts.
Cheng Q; Jiang S; Huang L; Wang Y; Yang W; Yang Z; Ge J
Toxicology; 2020 Jan; 429():152337. PubMed ID: 31760079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
